Bharat Rasayan Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
BHARATRAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 3.6 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bharat Rasayan Limited reported Q3 FY26 standalone revenue from operations of ₹270.46 crore, up about 5.5% from ₹256.40 crore in Q3 FY25. Standalone profit after tax for the quarter rose to ₹33.99 crore from ₹29.69 crore, a growth of roughly 14.5%. For the nine months ended December 2025, standalone revenue grew nearly 8% to ₹933.82 crore and PAT increased about 7.4% to ₹103.81 crore. Consolidated nine-month PAT was lower at ₹107.57 crore versus ₹115.79 crore last year due to a smaller share of profit from its joint venture, Nissan Bharat Rasayan. The company completed a 1:1 bonus issue and a stock split (face value ₹10 to ₹5) during the quarter, and continues to hold CARE AA- and A1+ credit ratings. Insurance claims for property damage at the Dahej plant's Block-D are still being processed, and the company reported exceptional items of ₹1.49 crore (negative impact) in Q3 standalone results.
The company posted steady revenue and earnings growth with operating margins expanding by about 60–110 basis points year-on-year, which is a positive signal. However, exceptional items distort standalone profit and consolidated earnings dipped year-on-year on weaker JV contribution, which investors should monitor.